Article Information
History
- August 29, 2024.
Article Versions
- Version 1 (February 4, 2024 - 08:06).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Sherry Masoud1,2,
- Katie Wong1,2,
- David Pitcher1,2,
- Lewis Downward1,
- Clare Proudfoot3,
- Nicholas J.A. Webb3,
- RaDaR Consortium4,
- Edwin K.S. Wong5 and
- Daniel P. Gale1,2,*
- 1National Registry of Rare Kidney Diseases, Bristol, United Kingdom
- 2Centre for Kidney and Bladder Health, University College London, United Kingdom
- 3Novartis Pharma AG, Basel, Switzerland
- 5National Renal Complement Therapeutics Centre, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
- ↵*Correspondence to: Professor Daniel P. Gale, UCL Department of Renal Medicine, Royal Free Hospital, Rowland Hill Street, London, NW3 2PF, d.gale{at}ucl.ac.uk.
Posted August 29, 2024.
Quantifying association of early proteinuria and eGFR changes with long-term kidney failure hazard in C3G and IC-MPGN
